Mazhar Ali Shah

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

Preferences regarding disclosure of prognosis and end-of-life care: A survey of cancer patients with advanced disease in a lower-middle-income country

Waleed Zafar, Haroon Hafeez, Arif Jamshed et al. · Palliative Medicine · 2016 · 36 citations

A phase II study of preoperative chemotherapy with irinotecan(CPT) and cisplatin(CIS) for gastric cancer(NCI 5917): FDG-PET/CT predicts patient outcome

Mazhar Ali Shah, Ho‐Man Yeung, Daniel G. Coit et al. · Journal of Clinical Oncology · 2007 · 30 citations

Preoperative Chemotherapy, Fdg Avid Patients, Esophageal Cancer +15

Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy

Abu Bakar Hafeez Bhatti, Amina Khan, Neelam Siddiqui et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 17 citations · Full text

Pleomorphic Liposarcoma Metastatic to the Thyroid Gland

Humayun Bashir, M. Nawaz, Mazhar Ali Shah et al. · Clinical Nuclear Medicine · 2002 · 15 citations